Sat, Dec 20, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Mid-November Equity Hedge Index up 0.38%, 9.1% year to date

Wednesday, November 20, 2013
Opalesque Industry Update - HFRX Equity Hedge Index posted a gain of +0.38% through mid-November, with gains across Fundamental Value and Market Neutral strategies adding to the YTD gain of +9.1% for the Index. HFRX Fundamental Value Index rose +0.57% with gains concentrated in US large-cap Consumer and Financial sectors, HFRX EH:FV leads all EH sub-strategies with YTD gain of +13.7%. HFRX Market Neutral Index gained +0.53%, with gains in mean reverting and fundamental, factor-based models.

HFRX Event Driven Index posted a gain of +0.21% through mid-November, with contributions from Merger Arbitrage and Equity Special Situations; HFRX ED leads all strategy indices with a gain of +13.1% YTD. HFRX Special Situations Index gained +0.34% for the month, continuing lead all sub-strategies with a YTD gain of +17.15%; the Index had contributions from core positioning in Elan, American Realty, Tribune Co., Ferro, Chemtura, Penn West and Life Technologies. HFRX Merger Arbitrage Index posted a gain of +0.21%, with contributions from transactions in NYSE/IntercontinentalExchange, Capital Source/Pacwest Bancorp, Akorn/Hi-Tech Pharmacal, FNB/BCSB Bancorp, Koch/Molex and Thermo Fisher/Life Technologies. The HFRX Distressed Index declined -0.17% for the period from various restructurings across Technology, Industrial and Basic Materials sectors.

HFRX Relative Value Arbitrage Index posted a decline of -0.10% through mid-November with modest declines across various fixed income strategies, including Convertible Arbitrage and Multi-Strategy managers. HFRX Convertible Arbitrage Index posted a decline of -0.87%, paring the YTD gain of the Index to +9.0%, with negative contribution from volatility and gamma positions. HFRX MLP Index gained +0.53% for the month, while the HFRX Fixed Income Credit Index posted a modest decline of -0.06% for the period.

HFRX Macro Index posted decline of -0.31% through mid-November, with positive contributions from Fixed Income & Systematic CTA strategies offset by weakness in Currency and Emerging Markets strategies. HFRX Macro: Systematic Diversified Index posted a gain of +0.09%, with contributions from equities, commodities and fixed income exposure. The HFRX Emerging Markets Index posted a decline of -0.95% from declines in Brazil and Currency exposure.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und